• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Abcuro Unveils Ulviprubart Phase 2/3 MUSCLE Study Results

    PHARMIWEB

    Abcuro`s KLRG1 Antibody Flunks Phase 2/3 Muscle Disease Study

    FIERCE BIOTECH

    Abcuro Presents Phase 1 Ulviprubart Data for T-LGLL at 67th ASH

    BUSINESSWIRE

    Abcuro To Present Ulviprubart Phase 1 Data at ASH Annual Meeting

    BUSINESSWIRE

    Abcuro Appoints George Eldridge as Chief Financial Officer

    BUSINESSWIRE

    Abcuro Raises $200M Series C To Advance Inclusion Body Myositis Drug

    BUSINESSWIRE

    Abcuro Announces Participation in Upcoming Investor Conferences

    BUSINESSWIRE

    Abcuro Completes Enrollment of Sentinel Cohort in Phase 2/3 Study of ABC008

    BUSINESSWIRE

    Abcuro Initiates Registrational Phase 2/3 Study of ABC008

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.